Study ID: ABS-AS-202
Study Title
- Efficacy and Safety Comparison of Albuterol Spiromaxֲ® and ProAirֲ® Hydrofluoroalkane (HFA) in Pediatric Patients
Teva Identifier
- ABS-AS-202
ClinicalTrials.gov Identifier
- NCT01899144
Study Status
- Completed
Trial Condition(s)
- Asthma
Interventions
- Drug: Albuterol Spiromax | Drug: ProAir HFA | Drug: Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 4 Years to 11 Years
Trial Duration
- 07/01/2013 - 10/01/2013
Phase
- Phase 2
Study Type
Interventional